<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35437">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02645240</url>
  </required_header>
  <id_info>
    <org_study_id>mansoura30</org_study_id>
    <nct_id>NCT02645240</nct_id>
  </id_info>
  <brief_title>Predictive Factors of Intestinal Infraction in Acute Mesenteric Ischemia</brief_title>
  <official_title>Predictive Factors of Intestinal Infraction in Patients With Acute Mesenteric Ischemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to identify several factors that can accurately predict the incident of
      intestinal infraction in patients with mesenteric vascular occlusion or ischemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims to identify several clinical, laboratory, and radiologic factors that can
      accurately predict the occurrence of intestinal infraction in patients with mesenteric
      vascular occlusion or ischemia in order to prevent unnecessary surgical intervention in
      patients with just intestinal ischemia and to hasten intervention in patients with actual
      intestinal gangrene.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical improvement</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of patients with resolved abdominal symptoms and incidence of patients developing shock</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Mesenteric Ischemia</condition>
  <arm_group>
    <arm_group_label>Heparin injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of low molecular weight heparin in patients with acute mesenteric ischemia to assess outcome</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Heparin injection</intervention_name>
    <description>Intravenous heparin injection in patients with acute mesenteric ischemia and evaluating their response within 24 hours</description>
    <arm_group_label>Heparin injection</arm_group_label>
    <other_name>Low molecular weight heparin injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with acute mesenteric Ischemia

        Exclusion Criteria:

          -  Patients with other causes of acute abdomen other than mesenteric Ischemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sameh H Emile, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura Univesity</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sameh H Emile, M.D</last_name>
    <email>Sameh200@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mansoura university hospital</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sameh Emile, M.D</last_name>
      <email>sameh200@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 21, 2017</lastchanged_date>
  <firstreceived_date>December 29, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Mesenteric Ischemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
    <mesh_term>Dalteparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
